X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
79
PharmaCompass offers a list of Carbamazepine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carbamazepine manufacturer or Carbamazepine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carbamazepine manufacturer or Carbamazepine supplier.
PharmaCompass also assists you with knowing the Carbamazepine API Price utilized in the formulation of products. Carbamazepine API Price is not always fixed or binding as the Carbamazepine Price is obtained through a variety of data sources. The Carbamazepine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Carbamazepine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carbamazepine, including repackagers and relabelers. The FDA regulates Carbamazepine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carbamazepine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carbamazepine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Carbamazepine supplier is an individual or a company that provides Carbamazepine active pharmaceutical ingredient (API) or Carbamazepine finished formulations upon request. The Carbamazepine suppliers may include Carbamazepine API manufacturers, exporters, distributors and traders.
click here to find a list of Carbamazepine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Carbamazepine DMF (Drug Master File) is a document detailing the whole manufacturing process of Carbamazepine active pharmaceutical ingredient (API) in detail. Different forms of Carbamazepine DMFs exist exist since differing nations have different regulations, such as Carbamazepine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Carbamazepine DMF submitted to regulatory agencies in the US is known as a USDMF. Carbamazepine USDMF includes data on Carbamazepine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Carbamazepine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Carbamazepine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Carbamazepine Drug Master File in Japan (Carbamazepine JDMF) empowers Carbamazepine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Carbamazepine JDMF during the approval evaluation for pharmaceutical products. At the time of Carbamazepine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Carbamazepine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Carbamazepine Drug Master File in Korea (Carbamazepine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Carbamazepine. The MFDS reviews the Carbamazepine KDMF as part of the drug registration process and uses the information provided in the Carbamazepine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Carbamazepine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Carbamazepine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Carbamazepine suppliers with KDMF on PharmaCompass.
A Carbamazepine CEP of the European Pharmacopoeia monograph is often referred to as a Carbamazepine Certificate of Suitability (COS). The purpose of a Carbamazepine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Carbamazepine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Carbamazepine to their clients by showing that a Carbamazepine CEP has been issued for it. The manufacturer submits a Carbamazepine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Carbamazepine CEP holder for the record. Additionally, the data presented in the Carbamazepine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Carbamazepine DMF.
A Carbamazepine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Carbamazepine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Carbamazepine suppliers with CEP (COS) on PharmaCompass.
A Carbamazepine written confirmation (Carbamazepine WC) is an official document issued by a regulatory agency to a Carbamazepine manufacturer, verifying that the manufacturing facility of a Carbamazepine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Carbamazepine APIs or Carbamazepine finished pharmaceutical products to another nation, regulatory agencies frequently require a Carbamazepine WC (written confirmation) as part of the regulatory process.
click here to find a list of Carbamazepine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Carbamazepine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Carbamazepine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Carbamazepine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Carbamazepine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Carbamazepine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Carbamazepine suppliers with NDC on PharmaCompass.
Carbamazepine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Carbamazepine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Carbamazepine GMP manufacturer or Carbamazepine GMP API supplier for your needs.
A Carbamazepine CoA (Certificate of Analysis) is a formal document that attests to Carbamazepine's compliance with Carbamazepine specifications and serves as a tool for batch-level quality control.
Carbamazepine CoA mostly includes findings from lab analyses of a specific batch. For each Carbamazepine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Carbamazepine may be tested according to a variety of international standards, such as European Pharmacopoeia (Carbamazepine EP), Carbamazepine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carbamazepine USP).
Market Place
